Loading company…
Neurodome develops non-invasive deep brain neural regulation devices and treatments.
Neurodome develops non-invasive deep brain neural regulation technology for central and peripheral nervous system diseases and chronic mental disorders. Its TIs EMO-1000/TIs CAP product provides precision stimulus control. The company is based in Xi'an, China, and was founded in 2019. In March 2026, it raised approximately CNY 100 million in Series A+ funding led by Mingxi Capital to advance products, clinical registration, and commercial expansion.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in